促胰液素/促胰液素受体信号在胆汁淤积性肝损伤中的功能作用
本综述总结了促胰液素/促胰液素受体轴在正常及胆汁淤积条件下对胆管细胞分泌、增殖、衰老及纤维化过程的调控作用,并汇总了原发性胆汁性胆管炎、原发性硬化性胆管炎等人类慢性胆汁淤积性肝病及动物模型中的相关数据,指出调控促胰液素通路可能成为慢性胆汁淤积性肝病的治疗途径。
要点
- 促胰液素/促胰液素受体轴不仅调节胆管分泌,还参与胆管细胞增殖、衰老及胆管上皮相关纤维化过程。
- 综述汇总了原发性胆汁性胆管炎和原发性硬化性胆管炎等人类慢性胆汁淤积性肝病及动物模型中的相关数据。
- 文中指出调控促胰液素通路可能作为慢性胆汁淤积性人类肝病的治疗途径。
核心结论
- 促胰液素/促胰液素受体轴在正常和胆汁淤积条件下对胆管上皮具有关键调控作用,调控该通路可能成为慢性胆汁淤积性人类肝病的治疗途径。
研究设计与样本
- 综述,检索并汇总促胰液素/促胰液素受体轴在正常及胆汁淤积条件下作用的相关研究,包括人类慢性胆汁淤积性肝病数据及模拟疾病的动物模型或人类相关性研究。
主要发现
- 促胰液素/促胰液素受体轴不仅调节胆汁分泌,还参与胆管细胞增殖和衰老,并促进涉及胆管上皮的纤维化过程。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The gastrointestinal peptide, secretin (Sct) is an important homeostatic regulator of pancreatic and liver secretory function. With regard to the liver, discoveries have been made, in the last decades, indicating a key role for the secretin/secretin receptor axis during normal or cholestatic conditions. Since large cholangiocytes are the only cells to express secretin receptor in the liver, research on secretin also expanded our knowledge on biliary epithelia. In this review we examined in detail the role of the secretin/secretin receptor axis, not only on biliary secretion, but also on cholangiocyte proliferation and senescence, as well as in prompting fibrotic processes involving biliary epithelia. Relevant data on human chronic cholestatic liver diseases, such as primary biliary cholangitis or primary sclerosing cholangitis, and obtained in animal models mimicking the diseases or in correlative studies on human are also reported. The aim of this review is to provide an update on the progress regarding the interactions between secretin and the biliary epithelia in normal and pathological conditions, underlining the aspects that suggests modulation of secretin pathway as a possible therapeutic approach for chronic cholestatic human liver disease.
引用
- Wu N, Baiocchi L, Zhou T, et al. Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury. Hepatology. 2020. PMID: 32737904. doi:10.1002/hep.31484
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。